Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Myrto Lee"'
Autor:
Myrto Lee, Hugo Larose, Martin Gräbeldinger, Jon Williams, Anne-Marie Baird, Susan Brown, Johannes Bruns, Russell Clark, Javier Cortes, Giuseppe Curigliano, Andrea Ferris, Louis P. Garrison, Y.K. Gupta, Ravindran Kanesvaran, Gary Lyman, Luca Pani, Zack Pemberton-Whiteley, Tomas Salmonson, Peter Sawicki, Barry Stein, Dong-Churl Suh, Galina Velikova, Jens Grueger
Publikováno v:
Health Policy Open, Vol 6, Iss , Pp 100116- (2024)
The move toward early detection and treatment of cancer presents challenges for value assessment using traditional endpoints. Current cancer management rarely considers the full economic and societal benefits of therapies. Our study used a modified D
Externí odkaz:
https://doaj.org/article/e4d6e9cf3a8d4b7d88dee937863945b9
Autor:
Hugo Larose, Myrto Lee, Jens Grueger, Amélie Anota, Nicolas Naïditch, Bruno Falissard, Mario Di Palma, Olivier Chassany, Laura Khalfallah-Neelz, Sarah Palazuelos-Muñoz, Aymeric Tetafort
Publikováno v:
Health Research Policy and Systems, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Objectives Patient’s health-related quality of life (HRQoL) is an important outcome measure that is considered by many payers and health technology assessment (HTA) bodies in the evaluation of treatments. We aimed to identify opportunities
Externí odkaz:
https://doaj.org/article/fc9bb172dbd546d6bf1e7b04e9e31049
Publikováno v:
Clinical Pharmacology and Therapeutics
At the turn of the century, the pharmaceutical industry began a transition toward a focus on oncology, rare diseases, and other areas of high unmet need that required a new, more complex approach to drug development. For many of these disease states
Autor:
Deming Qin, Stuart Faulkner, Liz Morrell, Pierluigi Russo, A. Sammarco, Myrto Lee, Richard J. Barker, Entela Xoxi, Luca Pani, Silvia Miriam Cammarata
Publikováno v:
Clinical pharmacology and therapeutics. 100(6)
© 2016 American Society for Clinical Pharmacology and Therapeutics Earlier patient access to beneficial therapeutics that addresses unmet need is one of the main requirements of innovation in global healthcare systems already burdened by unsustainab
Autor:
Bronwen A. Dekker, Surjeet Singh, Susan A. Watson, Andrew McKenzie, Myrto Lee, Hayden Beresford, Jane K. Sosabowski, Ben P. Simmons, Stephen J. Mather, Susan A. Hagan
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 31(2)
A DOTA-gastrin analogue (APH070) which, when labelled with (111)In, has high affinity for the gastrin/CCK-2 receptor (3nM) and low tumour to kidney ratio in animal models, has been formulated and manufactured for a clinical study. Oxidation of the pe